Radiolabeling of DOTATOC with the long-lived positron emitter 44Sc

Appl Radiat Isot. 2012 Jun;70(6):974-9. doi: 10.1016/j.apradiso.2012.03.005. Epub 2012 Mar 18.

Abstract

The positron-emitting radionuclide (44)Sc with a half-life of 3.97 h and a β(+) branching of 94.3% is of potential interest for clinical PET. As so far it is available from a (44)Ti/(44)Sc generator in Mainz, where long-lived (44)Ti decays to no-carrier-added (nca) (44)Sc. The (44)Sc is a trivalent metal cation and should be suitable for complexation with many well established bifunctional chelators conjugated to peptides or other molecular targeting vectors. Thus, the aim of this work was to investigate the potential of (44)Sc for labeling of DOTA-conjugated peptides. DOTA-D-Phe(1)-Tyr(3)-octreotide (DOTATOC) was used as a model molecule to study and optimize labeling procedure. Reaction parameters such as buffer conditions, concentration of peptide, pH range, reaction temperature and time were optimized. Addition of 21 nmol of DOTATOC to (44)Sc in ammonium acetate buffer pH 4.0 provided labeling yields >98% within 25 min of heating in an oil-bath at 95°C. This time can be reduced to 3 min only by applying microwave supported heating. (44)Sc-DOTATOC was found to be stable in 0.9% NaCl, PBS pH 7.4, fetal calf and human serums, and also in the presence of competing metal cations (Fe(3+), Ca(2+), Cu(2+), Mg(2+)), as well as other ligand competitors, like EDTA and DTPA, even after almost 25 h incubation at 37°C. Present study shows that nca (44)Sc forms stable complexes with the macrocyclic ligand DOTA and that (44)Sc-DOTATOC and analog targeting vectors may be synthesized for further preclinical and clinical investigations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Contrast Media / chemical synthesis
  • Isotope Labeling / methods*
  • Octreotide / analogs & derivatives*
  • Octreotide / chemical synthesis
  • Octreotide / isolation & purification
  • Positron-Emission Tomography / methods*
  • Radioisotopes
  • Radiopharmaceuticals / chemical synthesis*
  • Radiopharmaceuticals / isolation & purification
  • Scandium / chemistry*
  • Scandium / isolation & purification

Substances

  • Contrast Media
  • Radioisotopes
  • Radiopharmaceuticals
  • Octreotide
  • Edotreotide
  • Scandium